Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision label "Revision: v3.3.2" was added and the previous "Revision: v3.2.0" label was removed.SummaryDifference0.0%

- Check28 days agoChange DetectedThe notice about government funding status was removed, a non-substantive banner that does not affect the study details, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe new screenshot shows minor UI updates and small data refinements to the study record (e.g., updated dates/locations) while the core study design and outcome information remain unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference2%

- Check78 days agoChange DetectedRemoved a specific resource entry (Head and neck squamous cell carcinoma) and updated the page version to v3.1.0.SummaryDifference0.4%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the only other change is the removal of the Back to Top element, which is a minor UI tweak.SummaryDifference0.1%

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.